These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33906875)

  • 1. Nivolumab with radiation therapy in a glioblastoma patient with Lynch syndrome.
    Sherman WJ; Vitaz TW
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33906875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Presentation of Homozygous Mismatch Repair Deficient Glioblastoma in Teen With Lynch Syndrome: Implications for Treatment and Surveillance.
    Thomsen W; Maese L; Vagher J; Moore K; Cheshier SH; Hofmann JW; Bruggers C
    JCO Precis Oncol; 2021 Nov; 5():670-675. PubMed ID: 34994609
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab.
    Kawashima Y; Nishikawa S; Ninomiya H; Yoshida R; Takano N; Oguri T; Kitazono S; Yanagitani N; Horiike A; Ohyanagi F; Ishikawa Y; Nishio M
    Intern Med; 2019; 58(10):1479-1484. PubMed ID: 31092773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
    AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
    Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.
    Anghileri E; Di Ianni N; Paterra R; Langella T; Zhao J; Eoli M; Patanè M; Pollo B; Cuccarini V; Iavarone A; Rabadan R; Finocchiaro G; Pellegatta S
    Cancer Immunol Immunother; 2021 Mar; 70(3):831-842. PubMed ID: 33140187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
    T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
    Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lynch syndrome-associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome.
    Yang C; Austin F; Richard H; Idowu M; Williamson V; Sabato F; Ferreira-Gonzalez A; Turner SA
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31604779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
    Winer A; Ghatalia P; Bubes N; Anari F; Varshavsky A; Kasireddy V; Liu Y; El-Deiry WS
    Oncologist; 2019 Nov; 24(11):1416-1419. PubMed ID: 31444293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lynch Syndrome-Associated Glioblastoma Treated With Concomitant Chemoradiotherapy and Immune Checkpoint Inhibitors: Case Report and Review of Literature.
    Nakase K; Matsuda R; Sasaki S; Nakagawa I
    Brain Tumor Res Treat; 2024 Jan; 12(1):70-74. PubMed ID: 38317491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Diagnosed Lynch Syndrome in a Patient with Ureteral Cancer].
    Kobayashi G; Takayanagi A; Shindo T; Hashimoto K; Kobayashi K; Fukuta F; Tanaka T; Masumori N
    Hinyokika Kiyo; 2021 Jun; 67(6):229-232. PubMed ID: 34265897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lynch syndrome in colorectal cancer patients.
    Giráldez MD; Castellví-Bel S; Balaguer F; Gonzalo V; Ocaña T; Castells A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):573-83. PubMed ID: 18402524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lynch Syndrome/Hereditary Non-polyposis Colorectal Cancer (HNPCC).
    Stoffel EM
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):45-53. PubMed ID: 20190724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
    Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF
    J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare case of choroid plexus carcinoma that led to the diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Zhu VW; Hinduja S; Knezevich SR; Silveira WR; DeLozier CD
    Clin Neurol Neurosurg; 2017 Jul; 158():46-48. PubMed ID: 28460341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Undifferentiated Carcinoma of the Sella in a Patient with Lynch Syndrome.
    Voisin MR; Almeida JP; Perez-Ordonez B; Zadeh G
    World Neurosurg; 2019 Dec; 132():219-222. PubMed ID: 31491579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lynch syndrome: What is new?].
    Pellat A; Netter J; Perkins G; Cohen R; Coulet F; Parc Y; Svrcek M; Duval A; André T
    Bull Cancer; 2019; 106(7-8):647-655. PubMed ID: 30527816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair from Lynch syndrome to immunotherapy: A brief primer for cytopathologists.
    Kerr SE
    Cancer Cytopathol; 2020 Aug; 128(8):515-517. PubMed ID: 32196978
    [No Abstract]   [Full Text] [Related]  

  • 18. Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology.
    Cohen SA; Pritchard CC; Jarvik GP
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():293-307. PubMed ID: 30848956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair gone awry: Management of Lynch syndrome.
    Zhang T; Boswell EL; McCall SJ; Hsu DS
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):170-9. PubMed ID: 25459670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary prostate cancer as a feature of Lynch syndrome.
    Bauer CM; Ray AM; Halstead-Nussloch BA; Dekker RG; Raymond VM; Gruber SB; Cooney KA
    Fam Cancer; 2011 Mar; 10(1):37-42. PubMed ID: 20872076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.